PET scans for multiple myeloma patients receiving CAR T-cell therapy
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study tests a new imaging method (PET-enabled dual-energy CT) to see if it can better show how multiple myeloma responds to CAR T-cell therapy. It may help doctors personalize treatment and catch changes early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have multiple myeloma and are scheduled to receive a specific CAR T-cell therapy (like Idecel or Ciltacel).
- You are willing to fast for at least 6 hours before the scan and avoid strenuous exercise for 24 hours before.
- You can lie still on the scanner bed for up to 60 minutes.
- You are not pregnant or breastfeeding, and you haven't had a research PET scan in the last 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging method that uses a special tracer to find multiple myeloma cells in the body. It may help doctors see the disease more clearly and guide treatment.
This Phase 1 study tests a new special scan marker (a radioactive imaging agent) to see whether it can detect certain multiple myeloma spots in the body. If it works, it may help doctors better locate disease using a PET-style scan.
This trial uses a special imaging scan to see how CAR-T cells work in people with multiple myeloma. It may help doctors understand the treatment better.
This study uses a special imaging test called a PET scan to learn more about multiple myeloma and how it responds to treatment. The results may help doctors better predict outcomes and tailor care for people with newly diagnosed disease.
This trial tests a new type of PET scan that uses a radioactive tracer (68Ga-BCMA) to find active multiple myeloma cells in your body. It may help doctors better detect and monitor the disease.
This trial compares two types of PET/CT scans to see which one better finds lesions (areas of disease) in people with newly diagnosed multiple myeloma. If you qualify, you may help doctors choose the most useful scan to guide care.
Hear when a new Multiple Myeloma (MM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.